您的位置: 首页 > 农业专利 > 详情页

CD28 T CELL CULTURES, COMPOSITIONS, AND METHODS OF USING THEREOF
专利权人:
IMMATICS US; INC.
发明人:
Amir ALPERT,Mamta KALRA
申请号:
US16823987
公开号:
US20200297768A1
申请日:
2020.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A method for producing T cells with improved efficacy for adoptive immunotherapy includes obtaining a population of CD8+ T cells from a patient or a donor, determining a % of CD28+CD8+ T cells in the obtained population, activating the determined population with anti-CD3 antibody and anti-CD28 antibody, provided that the determined population comprises at least 50% of CD28+CD8+ T cells, or activating the determined population with anti-CD3 antibody in the absence of anti-CD28 antibody, provided that the determined population comprises less than 50% of CD28+CD8+ T cells, transducing the activated population with a viral vector, and expanding the transduced population, in which the transducing and the expanding are carried out in the presence of at least one cytokine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充